Investor Relations
Investors can contact YES INTERNATIONAL, the Company’s investor relations firm at (757)306-6090 regarding information about the publicly trading aspect at BioForce Nanosciences Holdings, Inc. which trades under the stock Symbol BFNH on OTCMARKETS.COM.
Corporate Officers / Directors
Merle Ferguson
Chairman of the Board, CEO, President
Richard Kaiser
Director/ Acting CFO/ Secretary
Trading Symbol: BFNH
US SEC 1934 Act Reporting Issuer: CIK 000131048
Exact title and class of securities outstanding: Common Stock, Par Value $0.001
CUSIP: 09064C107
Par or Stated Value: $0.001
Total shares authorized: 100,000,000 as of: 10/31/2000
Total shares outstanding: 76,305,023 as of: 11/13/2018
Exact title and class of securities outstanding: Preferred - Class ‘A’
CUSIP: None
Par or Stated Value: $0.001
Total shares authorized: 10,000,000 as of: 01/10/2006
Total shares outstanding: -0- as of: 11/13/2018